Drug by Ironwood spinout Cyclerion fails mid-stage trial; company plans cost cuts
October 30, 2019 at 08:17 AM EDT
New biopharma startup Cyclerion Therapeutics has stumbled out of the gate, disclosing Wednesday that one of its lead drug candidates failed in a mid-stage study.
